Stock Analysts’ updated eps estimates for Thursday, January 10th:

American Airlines Group (NASDAQ:AAL) had its target price cut by Cowen Inc from $43.00 to $42.00. Cowen Inc currently has an outperform rating on the stock.

Alkermes (NASDAQ:ALKS) had its buy rating reaffirmed by analysts at JPMorgan Chase & Co..

Johnson Rice started coverage on shares of Apergy (NYSE:APY). The firm issued an accumulate rating and a $38.00 target price on the stock.

Biogen (NASDAQ:BIIB) had its buy rating reaffirmed by analysts at JPMorgan Chase & Co..

bluebird bio (NASDAQ:BLUE) had its buy rating reiterated by analysts at JPMorgan Chase & Co..

Carnival (NYSE:CCL) had its outperform rating reaffirmed by analysts at Wells Fargo & Co. Wells Fargo & Co currently has a $70.00 price target on the stock, down from their previous price target of $76.00.

CATHAY PAC AIRW/S (OTCMKTS:CPCAY) was upgraded by analysts at Macquarie from a neutral rating to an outperform rating.

Delek US (NYSE:DK) had its neutral rating reaffirmed by analysts at Piper Jaffray Companies.

Editas Medicine (NASDAQ:EDIT) had its hold rating reaffirmed by analysts at JPMorgan Chase & Co..

Bank of America Corp started coverage on shares of Forestar Group (NYSE:FOR). They issued a buy rating and a $19.00 price target on the stock.

Greenbrier Companies (NYSE:GBX) had its market perform rating reaffirmed by analysts at Wells Fargo & Co. They currently have a $43.00 target price on the stock, down from their previous target price of $52.00.

Susquehanna Bancshares Inc started coverage on shares of General Dynamics (NYSE:GD). Susquehanna Bancshares Inc issued a neutral rating and a $175.00 target price on the stock.

Hawaiian (NASDAQ:HA) had its price target trimmed by Cowen Inc from $32.00 to $30.00. They currently have a market perform rating on the stock.

HollyFrontier (NYSE:HFC) had its neutral rating reiterated by analysts at Piper Jaffray Companies.

Incyte (NASDAQ:INCY) had its buy rating reiterated by analysts at JPMorgan Chase & Co..

L Brands (NYSE:LB) had its sell rating reiterated by analysts at Loop Capital. They currently have a $23.00 price target on the stock, down from their previous price target of $24.00.

Lockheed Martin (NYSE:LMT) had its equal weight rating reissued by analysts at Morgan Stanley.

Susquehanna Bancshares Inc started coverage on shares of Lockheed Martin (NYSE:LMT). The firm issued a positive rating and a $321.00 price target on the stock.

Marathon Petroleum (NYSE:MPC) had its overweight rating reissued by analysts at Piper Jaffray Companies.

Marina Biotech (OTCMKTS:MRNA) had its buy rating reiterated by analysts at JPMorgan Chase & Co..

Marvell Technology Group (NASDAQ:MRVL) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $26.00 target price on the stock. The analysts wrote, “We caught up with Marvell management at CES. Key Takeaways The storage pause (HDDs and SSDs), continues to be viewed as a 2 -quarter dynamic driven by macro economy factors, x86 CPU shortages at Intel (INTC: Sell), and deceler- ating CapEx spend in the data center markets. Management’s bullish stance mid to longer term is based on key storage wins at major hyperscale players in both HDD and SSD areas, HDD pre-amp share gains, and visibility for more wins in high capacity enterprise storage products. Marvell reiterated the notion that its biggest growth driver in the next few years is 5G base-stations due to dollar content expansion to nearly $3K per box from ~$700 per box in 4G.””

Maxim Integrated Products (NASDAQ:MXIM) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Maxim’s solid momentum across the automotive market remains a major positive. Further, the company remains optimistic about its flexible manufacturing strategy which is expected to aid margin expansion. Notably, the stock has outperformed the industry it belongs to over a year. However, Maxim's high dependence on Samsung is a risk to its growth trajectory. Also, the company is suffering from sluggish bookings and weakening momentum across its customers. These are affecting the company’s position in the industrial market. Further, it is experiencing seasonal fluctuations in the consumer market which remains an overhang. Also, slowing shipment of 100G optical module is likely to impact the company’s performance in data center market.”

Susquehanna Bancshares Inc started coverage on shares of Northrop Grumman (NYSE:NOC). They issued a neutral rating and a $273.00 target price on the stock.

PBF Energy (NYSE:PBF) had its overweight rating reiterated by analysts at Piper Jaffray Companies.

PerkinElmer (NYSE:PKI) had its average rating reaffirmed by analysts at CIBC. The firm currently has a $44.50 target price on the stock.

Prada (OTCMKTS:PRDSF) had its hold rating reissued by analysts at Berenberg Bank.

Phillips 66 (NYSE:PSX) had its overweight rating reissued by analysts at Piper Jaffray Companies.

Susquehanna Bancshares Inc assumed coverage on shares of Raytheon (NYSE:RTN). The firm issued a positive rating and a $187.00 target price on the stock.

Seattle Genetics (NASDAQ:SGEN) had its buy rating reissued by analysts at JPMorgan Chase & Co..

SkyWest (NASDAQ:SKYW) had its target price cut by Cowen Inc from $66.00 to $61.00. The firm currently has an outperform rating on the stock.

Spectrum Brands (NYSE:SPB) had its buy rating reissued by analysts at CIBC. CIBC currently has a $14.50 target price on the stock.

SSE PLC/S (OTCMKTS:SSEZY) had its outperform rating reissued by analysts at Credit Suisse Group AG.

Constellation Brands (NYSE:STZ) had its target price cut by BMO Capital Markets to $225.00. BMO Capital Markets currently has an outperform rating on the stock.

Synthetic Biologics (NYSEAMERICAN:SYN) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. They currently have $0.75 price target on the stock. According to Zacks, “Synthetic Biologics, Inc. is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. The Company is engaged in developing product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., formerly known as Adeona Pharmaceuticals, Inc., is headquartered in Ann Arbor, Michigan. “

SUZUKI MTR CORP/ADR (OTCMKTS:SZKMY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Suzuki Motor Corporation manufactures and markets motorcycles, automobiles and marine and power products. It provides terrain vehicles, mini-vehicles, sub-compact vehicles, standard-sized vehicles, outboard motors, engines for snowmobiles, electro senior vehicles and houses, as well as boats, motorized wheelchairs, electro-scooters, industrial equipment. The company operates primarily in Japan, Europe, Asia and internationally. Suzuki Motor Corporation is headquartered in Hamamatsu, Japan. “

TODS S P A/ADR (OTCMKTS:TDPAY) had its sell rating reiterated by analysts at Berenberg Bank.

Talend (NASDAQ:TLND) had its hold rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $42.00 price target on the stock.

Susquehanna Bancshares Inc started coverage on shares of Textron (NYSE:TXT). Susquehanna Bancshares Inc issued a neutral rating and a $52.00 target price on the stock.

VIVENDI SA/ADR (OTCMKTS:VIVHY) was upgraded by analysts at BNP Paribas from a neutral rating to an outperform rating.

Valero Energy (NYSE:VLO) had its overweight rating reiterated by analysts at Piper Jaffray Companies.

Receive News & Ratings for American Airlines Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Airlines Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.